Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The GETAFIX trial will test the hypothesis that favipiravir is a more effective treatment for COVID-19 infection in patients who have early stage disease, compared to current standard of care. This study will also provide an important opportunity to investigate the safety and tol...

Descripció completa

Dades bibliogràfiques

Autors principals:	Catherine R. Hanna, Kevin G. Blyth, Glenn Burley, Samantha Carmichael, Carol Evans, Samantha Hinsley, Ibrahim Khadra, Saye Khoo, Liz-Anne Lewsley, Robert R. Jones, Raman Sharma, Andrea Taladriz-Sender, Emma C. Thomson, Janet T. Scott
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2020-11-01
Col·lecció:	Trials
Matèries:	COVID-19 Randomised controlled trial protocol favipiravir inpatient outpatient
Accés en línia:	http://link.springer.com/article/10.1186/s13063-020-04891-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!